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Abstract
Objective To describe an “indirect” cervical nerve root
injection technique with a dorsal approach that should carry
less inherent risk than the “direct” cervical transforaminal
injection approach, and to compare the immediate post-
injection results of the two procedures.
Materials and methods The indirect and direct cervical
nerve root injection procedures are described in detail.
Fifty-three consecutive patients receiving the indirect nerve
root injections during 2009–2010 were age- and gender-
matched to 53 patients who underwent direct transforaminal
nerve root injections performed in 2006. Pain level data
were collected immediately before and 20–30 min after
each procedure. The percentages of pain change in the two
groups were compared using the unpaired Student’s t test.
Results Fifty-two men (mean age 49) and 54 women (mean
age 55) were included. The mean percentage of pain
reduction for patients receiving indirect nerve root injec-
tions was 38.4% and for those undergoing the direct nerve
root injections approach it was 43.2%. This was not
significantly different (P=0.455). No immediate or late
adverse effects were reported after either injection procedure.
Conclusions The indirect cervical nerve root injection
procedure is a potentially safer alternative to direct cervical
transforaminal nerve root injections. The short-term pain
reduction is similar using the two injection methods.
Introduction
Compression or irritation of a nerve root in the cervical spine,
either from a disc herniation or degenerative changes
involving the intervertebral foramen, can be a source of
considerable pain and disability, the most frequent incidence
(203 out of 1,000) occurring between the ages of 50 and 54
[1–4]. When conservative treatments fail to improve the
pain, many patients have increasingly been referred for
cervical transforaminal nerve root injections as an alternative
to surgery, injecting a combination of local anesthetic and
corticosteroid [1–3, 5–7]. A recent “best evidence synthesis”
report states that there is some evidence supporting short-
term symptomatic improvement of radicular symptoms when
the treatment involves a short (< 3) course of selective root
injections with corticosteroids [8], but there are no controlled
trials investigating the efficacy of this procedure [1–3, 5–9].
The literature to date supports a relatively low serious
adverse events rate of less than 1% for cervical trans-
foraminal nerve root injections [8]. However, increasing
reports have surfaced describing very rare but extremely
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serious complications, including several cases of either
transient or permanent tetraplegia, brain infarctions leading
to death, arterial dissection with resulting complications, or
cortical blindness [2, 3, 9–19]. Recent investigations appear
to link many of these serious complications to specific
steroid preparations that consist of large particles or
particles that coalesce into larger aggregates, forming
emboli that infarct the spinal cord or brain when inadver-
tently injected into an artery [2, 3, 10, 14–16]. Another
suggested etiology is inadvertent arterial penetration leading
to either dissection or vasospasm [15, 17, 18].
Owing to the very serious nature of these uncommon
complications, protocols have been suggested to reduce the
likelihood of such adverse events. These include: always
performing the procedures under imaging guidance (real-time
fluoroscopy or computed tomography); use of a non-
particulate steroid; injection of iodinated contrast agent using
digital subtraction imaging to detect vascular uptake before
injectingmedications; and a test dose of 1ml of local anesthetic
before injecting steroid [3, 9, 14, 15]. While these guidelines
are important to reduce the risks of serious complications
from cervical transforaminal nerve root injections, they
cannot guarantee that no adverse reaction will occur.
Inadvertent vascular penetration during this procedure has
been reported to be up to 19.4% using recommended imaging
guidance procedures, as outlined above [19]. However, with
the use of a contrast agent, some of these punctures are
recognized immediately, and the needle repositioned, before
the injection of potentially harmful medication.
Because of the risk of potentially serious adverse events
with the use of cervical transforaminal nerve root injections,
and as a direct result of two such cases in this specialized
orthopedic/rheumatology hospital, the radiology department
stopped carrying out this procedure in June 2008. However,
patients with intractable nerve root pain, who wish to avoid
surgery, need effective short-term treatment. The natural
history of cervical disc herniations with radiculopathy is often
an improvement in symptoms over time [20], and for many of
these patients, cervical transforaminal nerve root injections
helped them to cope, avoiding the risks and costs of surgery.
A recent abstract (Drape JL et al., presented at the 2007
annual meeting of the Radiological Society of North
America) suggested that patients with cervical radiculopathy
might indeed respond favorably to the safer procedure of
cervical facet joint injections, which may indirectly also
provide medication to the related nerve root. This was a very
small study consisting of only 17 patients; thus, further
investigation is indicated.
Starting in 2009, our hospital began providing the new
“indirect” approach, which uses a procedure similar to a
posterolateral facet injection to indirectly allow the medi-
cation to target the relevant cervical nerve root (henceforth
called the indirect cervical nerve root injection). Shortly
thereafter, a prospective study investigating the outcomes in
these patients was started, which is currently ongoing.
Therefore, the purposes of this paper are:
1. To describe the procedure for CT-guided indirect
cervical nerve root injections
2. To compare the immediate post-injection outcomes on
patients receiving this new indirect cervical nerve root
injection approach with patients receiving the more
traditional cervical transforaminal “direct” nerve root
injection
Materials and methods
The prospective indirect cervical nerve root injection part of
this study was approved by the institutional ethics review
board. The retrospective direct cervical transforaminal
nerve root injection part of the study used data routinely
collected in 2006 and patients signed informed consent
before their procedures. Therefore, specific ethics approval
for this aspect of the study was not required according to a
waiver issued by the ethics committee.
Indirect cervical nerve root injection procedure
The indirect injection procedure and its benefits as well as
the associated risks were discussed with the patient and
informed consent was obtained. All cervical indirect nerve
root injections were performed as outpatient procedures
with CT fluoroscopic guidance (40-detector row CT,
Philips Brilliance; Philips Medical Systems, Best, the
Netherlands) by radiologists experienced in spinal inter-
ventions. All radiologists proceeded according to a stan-
dardized protocol to ensure the consistency of the indirect
cervical nerve root injections. For the procedure, the patient
was placed prone on the CT table with the head in a straight
position and the forehead on a pillow for mechanical
support. A lateral scout image was obtained to select the
appropriate cervical level, then a CT acquisition was
performed over 2–3 cervical levels. The entry site on the
skin was chosen dorsal to the lateral aspect of the facet
joint, which was directly adjacent to the targeted cervical
foramen. Craniocaudal location information was transferred
from the CT control station to the skin with the built-in
laser navigation, and then the skin was disinfected. A
second needle with the cap still on was placed flat on the
skin surface to ascertain the correct mediolateral position
under CT fluoroscopy before a 23-gauge needle was
inserted into the skin. The needle position was aimed at
the lateral aspect of the chosen facet joint and adjusted in
several steps using CT fluoroscopy so that the needle tip
directly touched the bone of the facet joint (Fig. 1).
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An injection of 0.5 mL iopamidol (Iopamiro 200, 200 mg
of iodine per milliliter; Bracco, Milan, Italy) was performed to
verify the correct position of the needle tip while manually
holding the needle in position to avoid slight needle
dislocation due to the injection pressure (Fig. 2). The contrast
material distribution was monitored with a single CT
fluoroscopic scan (4 slices with a slice thickness of
3.75 mm; field of view, 15 cm; bone window setting): the
observed contrast material distribution with this indirect
cervical nerve root injection method was either dorsal to the
facet joint at the level of the targeted nerve root or a portion
of the injected contrast material was found lateral to the facet
joint or even ventral to the joint with direct contact with the
nerve root. Hence, in some patients who received an indirect
cervical nerve root injection the drugs had immediate and
direct contact with the targeted nerve root, as is usually the
case with the direct cervical transforaminal nerve root
injection approach. Following the injection of contrast
material, 4 mg (1 mL) of the non-particulate corticosteroid
preparation dexamethasone (Fortecortin Inject; Merck,
Darmstadt, Germany) was slowly injected. This was fol-
lowed by a slow injection of 1 mL of 0.2% ropivacaine
(Naropin 0.2%; Astra-Zeneca, Södertälje, Sweden).
Direct cervical transforaminal nerve root injection approach
The direct anterolateral approach for CT-guided cervical
transforaminal nerve root injections has been described in
the literature [5, 21]. All direct cervical transforaminal
nerve root injections were performed by radiologists with
the same level of experience in spinal interventions as for
the indirect cervical nerve root injections. While some
elements are identical to the indirect approach described
above, the following steps were performed differently. The
patient was placed supine on the CT table with the head
turned slightly to the side opposite to the injection site. The
entry site on the skin was chosen at the same level or
slightly ventral to the targeted cervical foramen on the CT
images correlating with a lateral or anterolateral approach in
order to avoid the carotid and jugular vessels. A 23-gauge
needle was inserted into the skin with the needle parallel to the
table or angled slightly dorsally. The needle position was
aimed at the posterior border of the cervical foramen and
adjusted in several steps using CT fluoroscopy so that the
needle tip was located at the outer edge of the posterior aspect
of the foramen, dorsal to the nerve root (Fig. 1).
An injection of 0.3 mL of iopamidol was performed to
verify the correct position of the needle tip (Fig. 3). The
intraforaminal or periradicular contrast distribution was
monitored with a single CT fluoroscopic scan. A quantity of
the crystalloid corticosteroid suspension triamcinolone (40 mg
[1.0 mL]; Kenacort A 40; Dermapharm, Munich, Germany)
and 1 mL of 0.2% ropivacaine were slowly injected.
Subjects
After a trial period of 3 months in 2009, during which the
radiologists became familiar and comfortable with the indirect
cervical nerve root injection procedure, 55 consecutive
patients who received an indirect cervical nerve root injection
were included in the study. Two patients had to be excluded
because they did not present for the follow-up data collection,
resulting in 53 patients. These 53 patients were matched for
age and gender with 53 other patients who had previously
received the traditional direct cervical transforaminal nerve
root injection. Starting with January 2006, consecutive direct
cervical transforaminal injection patients who were the exact
age and gender matches for the indirect cervical nerve root
injection patients were included in the study until all 53
indirect injection patients were matched. All of these patients
were referred to the radiology department with clinical signs
and symptoms of nerve root compression from disc hernia-
tion, degenerative intervertebral foraminal stenosis or a
combination of the two conditions.
As a routine part of all imaging-guided injection
procedures at this hospital, pain data are collected before
Fig. 1 Schematic figure of
cervical nerve root injections. a
Indirect cervical nerve root
injection. The needle is posi-
tioned at the dorsal border of the
facet joint and the injected drugs
reach the target indirectly. b
Direct cervical transforaminal
nerve root injection. The needle
is positioned at the ventral
border of the facet joint, which
forms the dorsal border of the
intervertebral foramen. The
injected drugs reach the target
directly. Ccarotid artery, V
vertebral artery, IJ internal
jugular vein
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and shortly after diagnostic or therapeutic injections. Using
the numerical rating scale (NRS) where 0 is no pain and 10
is unbearable pain, the radiologists report any change in
pain 20–30 min after the injection. This difference in pain
before and after injection was converted to a percentage
score. The age and gender matching of the patients was
done before calculating their percentage pain change.
Statistical analysis
The 2006 pain change data were given by the radiologists
as a direct percentage score, and were either decreased or
increased. In 2009–2010 these data was provided by the
exact numbers on the 11-point visual analog pain scale
(VAS) where 0 is no pain and 10 is unbearable pain. These
values were converted to a percentage change score, and
the mean percentage pain decrease or increase with the
standard deviations for both the indirect and direct nerve
root injection patients was compared using the unpaired
Student’s t test. P<0.05 was set as indicating statistical
significance. The computer software package SPSS (version
16; SPSS, Chicago, IL, USA) was used for statistical
calculations.
Results
The mean patient age for the two groups was 52 years (SD=
11.4 for the indirect cervical nerve root injection group and
SD=10.3 for the direct cervical transforaminal nerve injection
group) with an age range of 29–74 years. There were 52 men
and 54 women in the study, and the female patients were on
average 6 years older than the male patients in both groups
(mean age 55 years for women and 49 years for men). For the
53 patients receiving indirect cervical nerve root injections,
C7 was the most common nerve root level targeted (29
patients) followed by the C6 level (22 patients). Similarly, C7
was the most common injection level for the direct nerve root
injection patients (24 out of 53) and C6 was second with 20
patients receiving an injection at this level.
The mean percentage of pain decrease post-injection for
the patients receiving indirect cervical nerve root injections
was 38.4% (SD=34.5) and for patients undergoing the
traditional direct cervical transforaminal nerve root injec-
Fig. 2 Indirect cervical nerve root injection. a The needle and
contrast material are located behind the facet joint. b The needle is
located behind the facet joint; contrast material can be seen next to the
needle, but also lateral and in front of the facet joint next to the
extraforaminal portion of the nerve root. Transverse CT image
Fig. 3 Direct cervical transforaminal nerve root injection. The needle
and contrast material are located within the intervertebral foramen.
Transverse CT image
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tions it was 43.2% (SD=30.7). This was not statistically
significant (P=0.455).
There were no adverse effects reported after either of the
injection procedures.
Discussion
The purpose of this study was primarily to describe the
technique for this indirect cervical nerve root injection
method. Additionally, a comparison of the immediate post-
injection patient responses between the direct cervical
transforaminal nerve root injection and the indirect cervical
nerve root injection approaches was made.
The two patient groups were purposefully age and
gender matched before the immediate post-injection pain
responses were analyzed so that the risk of bias was
reduced. It is encouraging that although the direct nerve
root injection procedure had a slightly higher mean
percentage of pain reduction immediately after injection,
this was not statistically significantly better than the indirect
injection approach. The 43.2% pain reduction using the
direct injection method is consistent with a previous study
evaluating patient responses at this same time point after
injection [5] where 46% pain reduction was obtained. It
will be very interesting to follow these indirect nerve root
block patients over time to determine whether or not their
pain levels continue to improve beyond the immediate post-
injection time point. It seems logical that it may take longer
for the drugs to affect the involved nerve root using this
procedure as the injections are not performed directly over
the relevant anatomy, but at a slight distance. Even with the
direct nerve root injection approaches it has been shown
that the positive effects improve over time, at least up to
4 weeks using either liquid or crystalline steroid prepara-
tions [2, 22].
Another alternative to the traditional direct approach for
cervical transforaminal CT-guided nerve root injections is a
“modified direct” approach, the so-called dorsal approach
as described by Wolter et al. [23, 24]. With this method the
patient lies prone on the table and the needle is inserted
posterolateral to the nerve root foramen so that the tip of the
needle can be placed directly between the extra-foraminal
portion of the nerve root and the facet joint. This dorsal
approach, based on extraforaminal rather than transforami-
nal blocks, is suspected to be less prone to serious adverse
effects because puncturing the nerve root artery, the
vertebral artery but also the carotid and jugular vessels is
less likely compared with the transforaminal nerve root
injections for anatomical reasons [23, 24]. The technique
used in our study is markedly different from the so-called
dorsal approach described above because the tip of the
needle is not placed in an extra-foraminal position, but
rather dorsal to the facet joint and the therapeutic effect
originates from drugs that disperse to the extra-foraminal or
intra-foraminal portion of the nerve root either initially or a
few hours after the injection.
In the more commonly performed traditional cervical
transforaminal nerve root injection procedure, the mecha-
nism by which particulate steroids may enter the arterial
system and travel to the spinal cord and brain causing
infarction has been the subject of several recent papers [9–
19]. It is strongly suggested that the needle inadvertently
penetrates one of the small arteries (sometimes called
medullary feeding arteries, segmental arteries or radicular
arteries) within the intervertebral foramen [9]. These small
arteries are inconsistent in their anatomical course and thus
their location cannot be predicted in order to direct needle
placement away from them. They arise from the vertebral
arteries and may contribute to the distribution of the
anterior cervical artery [10, 11]. Indeed, many of the
reported cases of tetraplegia have the symptoms of a
cervical anterior spinal artery syndrome [10, 11] consistent
with accidental embolization to this vessel. The vertebral
artery has also been implicated as the source of needle
penetration and hence spinal cord or brain infarction [16–
18]. Based on the anatomy of the neck, puncture of the
nerve root artery, the vertebral artery or the carotid and
jugular vessels is extremely unlikely with our indirect
cervical nerve root injection approach and we therefore
expect this procedure to be safer than the cervical trans-
foraminal approach and the risk of serious adverse effects
to still be lower than with the dorsal approach used by
Wolter et al. [23, 24].
The indirect cervical nerve root injection is similar to the
technique used for CT-guided cervical facet joint infiltration
[25], except that there is no attempt to place the needle into
the joint itself and the non-particulate corticosteroid
preparation dexamethasone is used instead of a crystalloid
corticosteroid. Serious adverse effects in image-guided
cervical facet joint infiltration are rare [26].
A limitation to this study is the lack of longer term
follow-up for patients receiving both of these injection
procedures. Because the direct cervical transforaminal
nerve root injection procedure is no longer performed at
this hospital, it is not possible to obtain these data. Long-
term outcomes using the indirect cervical nerve root
injection procedure are currently being collected and will
be reported in due course. Ideally, a randomized clinical
trial would be carried out to compare outcomes from these
two injection approaches. However, this is not possible as
the direct procedure is no longer performed at this hospital
owing to concerns over possible adverse events. Another
limitation is that for the patient group who received a direct
cervical transforaminal nerve root injection in 2006, there
are no data recorded that indicate how many needle
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placements required repositioning because of intra-vascular
flow demonstrated by CT fluoroscopy. In the patient group
with the indirect cervical nerve root injection, however,
there were no cases where the needle had to be repositioned
owing to intra-vascular flow.
Conclusions
The indirect cervical nerve root block injection procedure is
described as a potentially safer alternative to the traditional
cervical transforaminal nerve root injection. The short-term
pain reduction is nearly as good using this indirect approach
compared with the traditional direct injection method.
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